Epidemiology of gastrointestinal and liver tumors

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 4, 2010, Pages 249-258

  Herszényi, Lászlo ^a   Tulassay, Zsolt ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Colorectal cancer; Epidemiology; Esophageal cancer; Gastric cancer; Hepatocellular carcinoma; Pancreatic cancer

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CALCIUM; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SELENIUM; URSODEOXYCHOLIC ACID; VITAMIN D;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DRUG MECHANISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ETHNIC DIFFERENCE; GASTROINTESTINAL TUMOR; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFESTYLE MODIFICATION; LIVER CELL CARCINOMA; PANCREAS CANCER; PUBLIC HEALTH PROBLEM; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL TIME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 77953152285     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. WEIR KKH, THUN MJ, HANKEY RIES LAG, HOWE HL, WINGO PA, JEMAL A, WARD E, ANDERSON RN, EDWARDS BK. Annual report of the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95: 1276-1299.
2. QUINN MJ. Cancer trends in the United States-a view from Europe. J Natl Cancer Inst 2003; 95: 1258-1261. (Pubitemid 37160849)
3. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, THUN MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
4. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, THUN MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
5. VERDECCHIA A, FRANCISCI S, BRENNER H, GATTA G, MICHELI A, MANGONE L, KUNKLER I, EUROCARE-4 WORKING GROUP. Recent cancer survival in Europe: a 2000-2002 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-796.
6. QUAGLIA A, TAVILLA A, SHACK L, BRENNER H, JANSSEN-HEIJNEN M, ALLEMANI C, COLONNA M, GRANDE E, GROSCLAUDE P, VERCELLI M, EUROCARE WORKING GROUP. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009; 45: 1006-1016.
7. FRANCISCI S, CAPOCACCIA R, GRANDE E, SANTAQUILANI M, SIMONETTI A, ALLEMANI C, GATTA G, SANT M, ZIGON G, BRAY Y, JANSSEN-HEUNEN M, EUROCARE WORKING GROUP. The cure of cancer: a European perspective. Eur J Cancer 2009; 45: 1067-1079.
8. MICHELI A, CIAMPICHINI R, OBERAIGNER W, CICCOLALLO L, DE VRIES E, IZARZUGAZA I, ZAMBON P, GATTA G, DE ANGELIS R, EUROCARE WORKING GROUP. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45: 1017-1027.
9. FERLAY J, AUTIER P, BONIOL M, HEANUE M, COLOMBET M, BOYLE P. Estimates of the cancer incidence and mortality in Europe 2006. Ann Oncol 2007; 18: 581-592.
10. MALVEZZI M, BOSETTI C, NEGRI E, LA VECCHIA C, DE-CARLI A. Cancer mortality in Italy: 1970-2002. Tumori 2008; 94: 640-657.
11. OTTÓ Sz. Cancer epidemiology in Hungary and the Béla Johan National Program for the decade of health. Pathol Oncol Res 2003; 9: 126-130.
12. OTTÓ Sz, KÁSLER M. Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programmes. Hungarian Oncol 2005; 49: 99-107.
13. KÁSLER M, OTTÓ Sz. European and Hungarian national tasks in oncology. Hungarian Oncol 2008; 52: 21-33.
14. TUSNÁDY G, GAUDI I, REJTO L, KÁSLER M, SZENTIRMAY Z. Survival of Hungarian cancer patients in the National Cancer Registry. Hungarian Oncol 2008; 52: 339-349.
15. YANG L, FUJIMOTO J, QIU D, SAKAMOTO N. Trends in cancer mortality in Japanese adolescents and young adults aged 15-29 years, 1970-2006. Ann Oncol 2009; 20: 758-766.
16. YANG L, FUJIMOTO J, QIU D, SAKAMOTO N. Trends in cancer mortality in the elderly in Japan, 1970-2007. Ann Oncol 2009; Jul 21 (Epub ahead of print).
17. BOYLE P, LANGMAN JS. ABC of colorectal cancer. Epidemiology. Br Med J 2000; 321: 805-808.
18. SOTO-SALGADO M, SUAREZ E, CALO W, CRUZ-CORREA M, FIGUEROA-VALLÉS NR, ORTIZ AP. Incidence and mortality rates for colorectal cancer in Puerto Rico among Hispanics, non-Hispanics, and non-Hispanic blacks in the United States. Cancer 2009; 115: 3016-3023.
19. SCHRAG D, CRAMER LD, BACH PB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93: 850-857.
20. RIM SH, SEEFF L, AHMED F KING JB, COUGHLIN SS. Colorectal cancer incidence in the United States, 1999-2004: an updated analysis of data from National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115: 1967-1976.
21. ASHKTORAB H, NOURAIE M, HOSSEINKHAH F, LEE E, ROTIMI C, SMOOT D. A 50-year review of colorectal cancer in African Americans: implications for prevention and treatment. Dig Dis Sci 2009; 54: 1985-1990.
22. SIEGEL RL, JEMAL A, WARD EW. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1695-1698.
23. DOZOIS EJ, BOARDMAN LA, SUWANTHANMA W, LIMBURG PJ, OMA RR, BAKKEN JL, VIERKANT RA, AAKRE JA, LARSON DW. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Baltimore) 2008; 87: 259-263.
24. WINAWER SJ, ZAUBER AG, HO MN, O'BRIEN MJ, GOTTUEB LS, STERNBERG SS, WAYE JD, SCHAPIRO M, BOND JH, PANISH JF. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981. (Pubitemid 24015040)
25. ALLISON JE, LAWSON M. Screening tests for colorectal cancer: a menu of options remains relevant. Curr Oncol Rep 2006; 8: 492-498.
26. REX DK, KAHI CJ, LEVIN B, SMITH RA, BOND JH, BROOKS D, BURT RW, BYERS T, FLETCHER RH, HYMAN N, JOHNSON D, KIRK L, LIBERMAN DA, LEVIN TR, O'BRIEN MJ, SIMMANG C, THROSON AG, WINAWER SJ. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2006; 130: 1865-1871.
27. WINAWER SJ, ZAUBER AG, FLETCHER RH, STILLMAN JS, O'BRIEN MJ, LEVIN B. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer and the American Cancer Society. Gastroenterology 2006; 130: 1872-1895.
28. REX D, JOHNSON DA, ANDERSON JC, SCHENFELD PS, BURKE CA, INADOMI JM. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol 2009. 24 February ; doi: 10.1038/ajg/2009.104.
29. PETERSON NB, MURFF HJ, NESS RM, DITTUS RS. Colorectal cancer screening among men and women in the United States. J Womens Health 2007; 16: 57-65. (Pubitemid 46302744)
30. PROVENZALE D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am 2002; 12: 93-109. (Pubitemid 34072784)
31. BJERREGAARD NC, TOTTRUP A, SORENSEN HT, LAURBERG S. Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer. Scand J Gastroenterol 2007; 42: 228-236. (Pubitemid 46253871)
32. REGULA J, RUPINSKI M, KRASZEWSKA E, POLKOWSKI M, PACHLEWSKI J, ORLOWSKA J, NOWACKI MP, BUTRUK E. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872. (Pubitemid 44664644)
33. BECKER F, NUSKO G, WELKE J, HAHN EG, MANSMANN U. Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations. Int J Colorectal Dis 2007; 22: 929-939.
34. TERHAAR SIVE DROSTE JS, TUYNMAN JB, VAN DULLEMEN HM, MULDER CJ. Chemoprevention for colon cancer: new opportunities, fact or fiction? Scand J Gastroenterol 2006; 41 (Suppl. 243): 158-164.
35. HERSZÉNYI L, PLEBANI M, CARRARO P, DE PAOLI M, ROVERONI G, CARDIN R, TULASSAY Z, NACCARATO R, FARINATI F. The role of cysteine and serine proteases in colorectal carcinoma. The role of cysteine and serine proteases in colorectal cancer. Cancer 1999; 86: 1135-1142.
36. HERSZÉNYI L, JUHÁSZ M, PRÓNAI L, TULASSAY Z. Chemoprevention of colorectal cancer. Orv Hetil 2004; 145: 603-610.
37. RAJU R, CRUZ-CORREA M. Chemoprevention of colorectal cancer. Dis Colon Rectum 2006; 49: 113-125.
38. HERSZÉNYI L, FARINATI F, MIHELLER P, TULASSAY Z. Chemoprevention of colorectal cancer: feasibility in everyday practice? Eur J Cancer Prev 2008; 17: 502-514.
39. CREW KD, NEUGUT AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362.
40. BRENNER H, ROTHENBACHER D, ARNDT V. Epidemiology of stomach cancer. Methods Biol 2009; 472: 467-477.
41. KUBO A, CORLEY DA. Marked regional variation in adenocarcinoma of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096-2102.
42. WANG XQ, TERRY PD, YAN H. Review of salt consumption and stomach cancer risk: epidemiology and biological evidence. World J Gastroenterol 2009; 15: 2204-2213.
43. BROWN LM, DEVESA SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235-256.
44. DEVESTA SS, BLOT WJ, FRAUMENI JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
45. VOUTILAINEN M. Epidemiological trends in oesophageal cancer in Nordic countries. Scand J Gastroenterol 2008; 43: 323-327. (Pubitemid 351238362)
46. BLOT WJ, DEVESA SS, KNELLER RW, FRAUMENI JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289.
47. CRANE SJ, LOCKE GR, HARMSEN WS, DIEHL NN, ZINSMEISTER AR, MELTON J, ROMERO Y, TALLEY NJ. The changing incidence of esophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007; 25: 447-453.
48. KORT EJ, SEVENSMA E, FITZGERALD TL. Trends in esophageal cancer and body mass index race and gender in the state of Michigan. BMC Gastroenterol 2009; 9: 47.
49. HERSZÉNYI L, PREGUN I, TULASSAY Z. Diagnosis and recognition of early esophageal neoplasia. Dig Dis 2009; 27: 24-30.
50. SPECHLER SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002; 346: 836-842.
51. COOK MB, GREENWOOD DC, HARDIE LJ, WILD CP, FORMAN D. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 2008; 103: 292-300.
52. EL-SERAG HB, KVAPIL P, HACKEN-BITAR J, KRAMER JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005; 100: 2151-2156. (Pubitemid 43919712)
53. CORLEY DA, KUBO A, LEVIN TR, BLOCK G, HABEL L, ZHAO W, LEIGHTON P, RUMORE G, QUESENBURRY C, BUFFLER P, PARSONNET J. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008; 57: 727-733.
54. RASTOGI A, PULI S, EL-SERAG HB, BANSAI A, WANI S, SHARMA P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and highgade dysplasia: a meta-analysis. Gastrointest Endosc 2008; 67: 394-398. (Pubitemid 351260043)
55. ANANDASABAPATHY S, JHAMB J, DAVIAL M, WEI C, MORRIS J, BRESALIER R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007; 109: 668-674.
56. THARAVEJ C, HAGEN A, PETERS H, PORTALE G, LIPHAM J, DEMEESTER SR, BREMNER CG, DEMEESTER TR. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc 2006; 20: 439-443.
57. WANG KK, SAMPLINER RE; PRACTICE PARAMETERS COMMITTEE OF THE AMERICAN COLLEGE OF GASTROENTEROLOGY. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-797.
58. MEINING A, OTT R, HAHN S, MÜHLEN M, HÖFLER H, CLASSEN M, HELDWEIN W, RÖSCH T. The Munich Barrett follow-up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only - what is the clinical significance? Gut 2004; 53: 1402-1407.
59. BERGMAN JGHM, TYTGAT GNJ. New developments in the endoscopic surveillance of Barrett's oesophagus. Gut 2005; 54(Suppl I): i38-i42.
60. CRANE SJ, LOCKE GR, HARMSEN WS, ZINSMEISTER A, ROMERO Y, TALLEY NJ. Survival trends in patients with gastric and esophageal adenocarcinoma: a population-based study. Mayo Clin Proc 2008; 83: 1087-1094.
61. DERAKSHAN MH, LITPROT S, PAUL J, BROWN IL, MORRISON D, McCOLL KEL. Oesophageal and gastric intestinal type-adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 2009; 58: 16-23.
62. SCHMITT CM, BRAZER SR. Clinical aspects of esophageal cancer. In Rustgi AK. ed. Gastrointestinal Cancers. Saunders, 2003.
63. REISER M, SCHMIEGEL W. Clinical aspects of pancreatic and ampullary cancers. In Rustgi AK. ed. Gastrointestinal Cancers. Saunders, 2003.
64. MICHAUD DS. Epidemiology of pancreatic cancer. Minerva Chir 2004; 59: 99-111.
65. LUKE C, PRICE T, KARAPETIS C, SIGNHAI N, RODER D. Pancreatic cancer epidemiology and survival in an Australian population. Asian Pac J Cancer Prev 2009; 10: 369-374.
66. HENSON DE, SCHWARTZ AM, NSOULI H, ALBORES-SAAVEDRA J. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of Vater share a field for carcinogenesis. Arch Pathol Lab Med 2009; 133: 67-71.
67. HART AR, KENNEDY H, HARVEY I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008; 6: 275-282. (Pubitemid 351318383)
68. LI D, MORRIS JS, HASSAN MM, DAY RS, BONDY ML, ABBRUZZESE JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553-2562.
69. BAO Y, GIOVANUCCI E, FUCHS CS, MICHAUD DS. Passive smoking and pancreatic cancer in women: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2292-2296.
70. WOLPIN BM, STAMPFER MJ. Defining determinants of pancreatic cancer risk: are we making progress? J Natl Cancer Inst 2009; 101: 972-973.
71. MCGLYNN KA. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19: 3-23. (Pubitemid 40331495)
72. CHUANG SC, LA VECCHIA C, BOFFETTA P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286: 9-14.
73. FRANCESCHI S, RAZA SA. Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett 2009; 286: 5-8.
74. SCHÜTTE K, BORNSCHEIN J, MALFERTHEINER P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 2009; 27: 80-92.
75. HERSZÉNYI L, FARINATI F, CECCHETCO A, MARAFIN C, DE MARIA N, CARDIN R, NACCARATO R. Fine-needle biopsy in focal liver lesions: the usefulness of a screening program and the role of cytology and microhistology. Ital J Gastroenterol 1995; 27: 473-478).
76. FATTOVICH G, STROFFOLINI T, ZAGNI I, DONATO F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: S35-S50.
77. EL-SERAG H, MASON AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750. (Pubitemid 29114292)
78. LA VECCHIA C, LUCCHINI F, FRANCESCHI S, NEGRI E, LEVI F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000; 36: 909-915. (Pubitemid 30214142)
79. STROFFOLINI T. Etiological factor of hepatocellular carcinoma in italy. Minerva Gastroenterol Dietol 2005; 51: 1-5. (Pubitemid 44251914)
80. MORGAN TR, MANDAYAM S, JAMAL MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl 1): S87-S96.
81. Yu MC, YUAN JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl 1): S72-S78.
82. KUMAR M, KUMAR R, HISSAR SS, SARASWAT MK, SHARMA BC, SAKHUJA P, SARIN SK. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007; 22: 1104-1111.
83. POLESEL J, TALAMINI R, MONTELLA M, MASO LD, CROVATTO M, PARPINEL M, IZZO F, TOMMASI LG, SERRAINO D, LA VECCHIA C, FRANCESCHI S. Nutrients intake and the risk of hepatocellular carcinoma in Italy. Eur J Cancer 2007; 43: 2381-2387. (Pubitemid 47625967)
84. POLESEL J, ZUCCHETTO A, MONTELLA M, DEL MASO L, CRISPO A, LA VECCHIA C, SERRAINO D, FRANCESCHI S, TALAMINI R. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-357.
85. MUELLER S, MILLONIG G, SEITZ HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009; 15: 3462-3471.